BioM Biotech Cluster Development GmbH

Fostering Innovation & Collaboration between India and Bavaria We were honoured to welcome the Indian Consul General, Shatrughna Sinha, to BioM Biotech Cluster Development GmbH and the IZB - Innovation and Start-up Center Biotechnology in Martinsried. It was a valuable opportunity to gain insight into the potential for collaboration between India's tech expertise, particularly in digital sciences, and Bavaria's biotech advancements. Prof. Ralf Huss and Christian Gnam took the opportunity to draw attention to the thriving ecosystem here in Bavaria. Our discussion focused on: 🌍 Collaboration Opportunities: Strengthening ties between India and Bavaria in the life sciences & tech industry. 📈 Identifying Promising Ventures: What attracts investors to biotech companies? 💡 Leveraging Technology: The role of data in accelerating drug development. Klaus Heumann from Labvantage - Biomax GmbH shared his insights from the industry in this discussion as well. Labvantage - Biomax serves as an excellent illustration of the potential for collaboration by enabling digital transformation within the biotech and pharmaceutical sectors. #LifeSciences #Innovation #FutureOfBiotech #BavariaMeetsIndia #InternationalRelations

📢 Do you also have a promising spin-off idea like Plectonic Biotech? Do you also want to win EUR 500,000 for it? Plectonic Biotech, our 2019 #m4Award winner, has developed the #LOGIBODY technology to fight #cancer. LOGIBODY is a DNA-based ultra-miniaturized nanoswitch that specifically recognizes cancer cells, directing the immune response precisely against cancer while sparing healthy tissue. Benjamin Kick, co-founder and COO of Plectonic Biotech says: „The m4 Award was a crucial step for transferring the LOGIBODY technology into a spin-off company.” Here are the key facts the 8th round of the #m4Award - Pre-Seed Competition for the Medicine of the Future”: ❓What? The 🏆pre-seed competition m4 Award is awarded by the Bavarian State Ministry of Economic Affairs, State Development and Energy. ❓Who? The m4 Award is aimed at 👨🔬#academic #research projects with spin-off potential in the field of #biomedicine. ❓Why? Up to five teams receive 💶 500.000 Euro for 2 years - to ensure the ability to obtain follow-up #financing. In addition, all awarded projects receive intensive project support on the way to #founding a company. ⏳ Until 21 November 2024, you have time to submit a short description (5 pages) of your business idea a market/competition overview, your unique selling points, a property rights situation/strategy, a work plan and financial plan. Find more information and our application form at ℹ️ www.m4-award.org #m4Award2025 #innovationfromBavaria #biotechnology #research #spinoff #entrepreneurship #preseed #Bavaria

Short reminder! Join us next week for a 𝗳𝗿𝗲𝗲 𝘀𝗲𝗺𝗶𝗻𝗮𝗿 over a 🥨 Bavarian Breakfast and discover why a robust bioanalytical strategy is crucial in modern #drugdevelopment. 👉 𝗕𝗶𝗼𝗔𝗴𝗶𝗹𝘆𝘁𝗶𝘅 𝗕𝗿𝗲𝗮𝗸𝗳𝗮𝘀𝘁 𝗦𝗲𝗺𝗶𝗻𝗮𝗿 𝗮𝘁 𝗕𝗶𝗼𝗠: 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 – 𝗕𝗶𝗼𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 & 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 👈 📅 Date and Time: Wednesday, 6 November 2024, 9.00 am - 1.00 pm 📍 Location: BioM Biotech Cluster Development GmbH, Martinsried, Germany More Information and 🆓 registration: https://lnkd.in/ew9j9FmJ Learn how to minimize risks, save time, and cut costs as you advance your molecule from early discovery to #marketapproval - ultimately delivering life-saving therapies to patients faster. Look forward to expert presentations of Dr. Mark Spengler, Robert Nelson, PhD and Dr. Christopher Tiedje, of BioAgilytix Europe GmbH and Dr. Katharina Kern, Formycon AG. 𝗬𝗼𝘂𝗿 𝗸𝗲𝘆 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲: ✅ Understand the critical role of state-of-the-art bioanalytical strategies in modern #drugdevelopment to mitigate study risks and secure timelines to advance therapeutic developments from #earlystage #discovery to #marketapproval fast. ✅ Learn about science, guidance and #regulatory concepts in bioanalytical study support for the #biotech and #pharmaceutical industry. ✅ Network and discuss with industry leaders and experts, both from drug development as well as from service provider perspective. ✅ Gain valuable insights that can be applied to your work, whether in #research, development, or operational roles. Learn how to streamline your development process and accelerate your therapeutic’s journey to market. ⏳ 𝗣𝗹𝗲𝗮𝘀𝗲 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗯𝗲𝗳𝗼𝗿𝗲 𝘁𝗵𝗲 5𝘁𝗵 𝗼𝗳 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2024.⏳ Due to limited seating, we encourage early registration to secure your spot! #biotechnology #pharma #seminar #drugdiscovery #marketapproval #Munich

✅ 28.000 children screened for Familial Hypercholesterolaemia (FH) in the #VRONIstudy. ✅ >180.000 downloads of #HerzFIT-App for cardiovascular risk assessment and lifestyle adapations. ✅ Large patient datasets with multi-omics analyses for compliant research, enable new insights into ❤️🩹 #atherosclerosis and health mechanisms, and how to diagnose, prevent and cure. ✅ A secure and collaborative “DigiMed Bayern Secure Cloud” for #healthdata in #atherosclerosis research, launched in 2023. 👉 That’s all outcome of the future medicine flagship project #DigimedBayern. Successful projects to improve the prevention, diagnosis, and therapy of killer no. 1 – #cardiovasculardisease with its fatal consequences – #heartattack and #stroke. Next week it is time for a recap! Prof. Dr. med. #HeribertSchunkert, MD will talk about the “changes in the digital landscape of #cardiovascular #medicine after 6 years of DigiMed Bayern” and surely we will get a prospect of what is yet to come this this year’s 👉 “𝗗𝗶𝗴𝗶𝗠𝗲𝗱 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝟮𝟬𝟮𝟰: 𝗕𝗶𝗴 𝗱𝗮𝘁𝗮 𝗳𝗿𝗼𝗺 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 – 𝗿𝗲𝗹𝗲𝘃𝗮𝗻𝘁 𝘁𝗼 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱, 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝗮𝗻𝗱 𝗰𝘂𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲?” 👈 📅 on 6 November 📍at the TranslaTUM of #TUM University Hospital in Munich! Register now! ➡️ https://lnkd.in/eky7JHrN Prof. Schunkert is Scientific Director of DigiMed Bayern, Professor of Cardiology of the Technische Universität München and Director of the Cardiology Department at the Deutsches Herzzentrum München since 2012. He conducts research on the molecular genetics of multifactorial #cardiovascular disease, coordinated several EU- and BMBF-sponsored projects as well as the European-American Leducq network CADgenomics to identify the genetic roots of #myocardialinfarction. More renowned speakers on the #futureofmedicine will be: Judith Gerlach, Bavarian State Minister for Health, Care and Prevention | Dr. med. Dr Martin Siess, TUM University Hopital | Dr. Jens Wiehler, BioM Biotech Cluster Development GmbH | Prof. Dr. Daniel Rueckert, TUM University Hopital | Prof. Dr. med. Prof. Dr. med. Steffen Massberg, LMU Klinikum München | Dr. med. Mike Mendelson, Novartis Institute For Biomedical Research | Prof. Dr. Tobias Dreischulte, #LMU Institute of General Practice and Family Medicine | Dr. med. Nils Krüger, TUM University Hopital | Dr. Holger Prokisch, TUM Universitätsklinikum Klinikum rechts der Isar | Dr. med. Fabian Starnecker, Technical University of Munich | Dr. Lara Marie Reimer, Universitätsklinikum Bonn  | Dr. med. veronika sanin, Deutsches Herzzentrum München – Vroni-Studienbüro | Prof. Dr. med. Lars Maegdefessel, TUM University Hopital | Dr. med. Dr. med. Moritz von Scheidt, Deutsches Herzzentrum München | Prof. Dr. med. Alena Buyx, Technische Universität München | Prof. Dr. Juliane Winkelmann, Helmholtz Munich/#TUM #DigiMedBayernSymposium #DMS2024 #DigitalHealthSummit #DHS2024 #DigitalHealth #evidencebasedmedicine #healthcarebenefits

In 3 weeks capital will meet #biotech/ #healthtech / #medtech innovation! Whether you're a #startup, growth-stage company, or publicly listed, there's a stage for you. Present your cutting-edge solutions, get feedback from seasoned experts, and capture the interest of #investors and partners specifically aligned with your growth stage and sector. 𝗛𝗲𝗿𝗲 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗸𝗲𝘆 𝗳𝗮𝗰𝘁𝘀: 👉 Investival Showcase 2024 👈 📅 When? 18 November 2024 📍Where? Tobacco Dock, London ➡️ Find more information at: https://lnkd.in/eHwJKfk2 A special discount of 15% on tickets applies for members of the BioM Biotech Cluster Development GmbH Biotech Community. Please contact Ms. Ariane Doischer at doischer@bio-m.org to receive the discount code. 𝗨𝗻𝗹𝗼𝗰𝗸 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝘄𝗵𝗮𝘁 𝗶𝘀 𝗶𝗻 𝘀𝘁𝗼𝗿𝗲 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝘃𝗮𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲. Expect: ✅ Keynote Speeches: Hear from top experts and influential figures shaping the future of #investment. ✅ Panel Discussions: Engage with thought-provoking discussions on emerging trends, market insights, and #investmentstrategies. ✅ #Networking Opportunities: Connect with like-minded professionals, potential partners, and future collaborators. ✅ Exhibitor Showcases: Explore innovative products and services from cutting-edge companies. See you in London! 🇬🇧 #biotechnology #lifesciences #capitalmarket #meetinvestors #founder #collaboration #innovation #biotechtrends

📢 Unsere neueste Ausgabe des „BioM-Newsletters“ ist da! Alle Neuigkeiten, aktuellen #BioM-Events und interessante Veranstaltungen mit spannenden Themen, Discounts und attraktiven Beteiligungsmöglichkeiten, sowie die neuesten Stellenangebote aus der bayerischen #Biotechnologie, finden Sie hier: ➡️ https://lnkd.in/e_RvKHdU ▶ HIGHLIGHTS  🔹 Christian Gnam vom IZB - Innovation and Start-up Center Biotechnology im BioM-Podcast: "Biotech-Unternehmen sind die risikoaffinsten, die Extremsportler unter den Start-ups“ ▶ NACHRICHTEN von und zu 🔹 cureVision GmbH, den Medical Valley EMN e. V. Award-Gewinnern, Technische Universität München, Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME, #GCT National Strategy Gene- and Cell-based Therapies #Genovate und BIO International Convention. Jede zweite Woche spannende Nachrichten, interessante Veranstaltungen und neueste Stellenangebote aus der #Biotech-Branche in #München und #Bayern mit dem #BioM-Newsletter: Jetzt abonnieren unter 📬 https://lnkd.in/e45YX4Cc #BiotechnologieinBayern #StandortDeutschland #Medizin #LifeScience #Investionen #Forschung

Erleben Sie die spannende Dynamik der #klinischeForschung hautnah! In 4 Wochen bietet das #BVMA-#Symposium bietet eine exzellente Plattform, um die neuesten technologischen Entwicklungen und die raschen Fortschritte in den Bereichen #Regulierung, #Innovation, #KI und praktische Anwendungen zu diskutieren.   Seien Sie dabei beim 32. Symposium des BVMA - Bundesverband Medizinischer Auftragsinstitute e.V.:  #𝗦𝘁𝘂𝗱𝗶𝗲𝗻𝘀𝘁𝗮𝗻𝗱𝗼𝗿𝘁𝗗𝗲𝘂𝘁𝘀𝗰𝗵𝗹𝗮𝗻𝗱 – 𝗡𝗲𝘂𝗲 𝗜𝗺𝗽𝘂𝗹𝘀𝗲 𝗳ü𝗿 𝗱𝗶𝗲 𝗸𝗹𝗶𝗻𝗶𝘀𝗰𝗵𝗲 𝗙𝗼𝗿𝘀𝗰𝗵𝘂𝗻𝗴“ 📅 Wann? am 22. November 2024 📍 Wo? im Holiday Inn Munich - City Centre, #München ➡️ Anmeldung unter: https://lnkd.in/dWen6_J   Mit dem baldigen Inkrafttreten des #Medizinforschungsgesetzes in diesem Jahr wird 🇩🇪 Deutschland einen ersten Schritt nach vorne machen, um bestehende Hürden zu überwinden und innovative Lösungen zu fördern.   Diskutieren Sie mit Experten und Fachleute aus der Branche. Diese werden Ihnen tiefgehende Einblicke geben und in einer inspirierenden Round-Table-Diskussion die Zukunft des Studienstandorts Deutschland beleuchten   Bereits am 𝗩𝗼𝗿𝗮𝗯𝗲𝗻𝗱 (21. 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿, 𝗮𝗯 19:00) gibt es das traditionelle #Get-together mit 🍡Snacks und 🧋Drinks im Veranstaltungshotel. Nutzen Sie diese Gelegenheit, vertraute Gesichter zu treffen, neue Kontakte zu knüpfen und in entspannter Atmosphäre anregende Gespräche zu führen. #BVMASymposium #Networking #ForschunginDeutschland #klinischeStudien

💸 Investment is often described as the lifeblood of the #pharma industry, especially for #biotech. How has investment in biotech developed in 🇪🇺 Europe over the last few years, and how might it continue to develop? 📰 Read the article “The European quilt of biotech investments – a patchwork of financial bargains” by Prof. Dr. Ralf Huss, Managing Director of #BioM and spokesperson of the #BavarianBiotechCluster here: ➡️ https://lnkd.in/e7MiAFM2 Now published in the #EBR #BioEurope Supplement 2024 of this year’s #BIOEurope taking place on 4 – 6 November in Stockholm. Thanks to Natalia Elliot and Louise Wilson-English MA of Samedan Ltd. for the pleasant collaboration! European Biopharmaceutical Review (EBR), BIO-Europe Supplement, Autumn 2024, pages 35-38. © Samedan Ltd #BIOEurope #Investment #biotechinvestments #Europe #Germany #biotechnology #innovation #finance #capital #investors #article

"Biotech-Unternehmen sind die risikoaffinsten, die Extremsportler unter den Start-ups", sagt Christian Gnam. Er ist seit 1. April neuer Geschäftsführer des IZB - Innovation and Start-up Center Biotechnology und spricht im aktuellen BioM-#Podcast über seine Motivation, diese Rolle zu übernehmen, was ihn am meisten an #Biotech fasziniert und welche Visionen er für das #IZB und den Standort #Martinsried hat. 🎧 Jetzt reinhören: https://lnkd.in/dwEdnTrz 🎤 Auch auf Spotify, Apple Podcasts etc. Vielen Dank Christian Gnam und Marion Köhler für die tolle Zusammenarbeit und das spannende Interview mit unserem Produzenten Edmund Soutschek!

Nächsten Montag geht’s weiter! Verpassen Sie nicht das dritte Webinar unserer Reihe 👉 „Kooperation bei Gesundheitsdaten“. 💡Dieses Mal behandelt Prof. Dr. Beatrix Weber, MLE, Professorin für Gewerblichen Rechtsschutz und IT-Recht sowie Leiterin Forschungsgruppe Recht in Nachhaltigkeit, Compliance und IT an der Hochschule Hof, University of Applied Sciences, die 🎤 𝗥𝗲𝗰𝗵𝘁𝘀𝗸𝗼𝗻𝗳𝗼𝗿𝗺𝗲 𝗡𝘂𝘁𝘇𝘂𝗻𝗴 𝘃𝗼𝗻 𝗚𝗲𝘀𝘂𝗻𝗱𝗵𝗲𝗶𝘁𝘀𝗱𝗮𝘁𝗲𝗻 𝘇𝘄𝗶𝘀𝗰𝗵𝗲𝗻 𝗢𝗿𝗴𝗮𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻𝗲𝗻 📅 28. Oktober 2024, 15:00 - 15:45 Uhr 🆓 Jetzt anmelden: ➡️ https://lnkd.in/eaFvFfPz ❓Wie mit Gesundheitsdaten umgehen? In der 3-teiligen Webinarreihe von Medical Valley EMN e. V. / Bayern Innovativ GmbH und BioM Biotech Cluster Development GmbH diskutieren wir das Thema aus ethischer, rein rechtlicher sowie auch aus der technologisch forschenden Perspektive. #KooperationGesundheitsdaten #Gesundheitsdaten #Gesundheitsdatennutzung #RechtlicherRechtsschutz #ITRecht #Recht #Compliance #Datenaustausch #TREs